Dr. Reddy’s Laboratories

Shares of Dr Reddy's slipped 7 per cent in early trade on May 11Shares of Dr Reddy's slipped 7 per cent in early trade on May 11, a day after the company posted its Q4 resultsShares of Dr Reddy’s Laboratories slipped 7 per cent in early…

In another development, Dr. Reddy’s Laboratories said it has introduced Regadenoson Injection 0.4 mg/5 mL, a generic therapeutic equivalent of Astellas US LLC’s Lexiscan (Regadenoson) injection, in the U.S. market. | Photo Credit:…

Representational image only. | Photo Credit: Special Arrangement Dr. Reddy’s Laboratories (DRL) is acquiring the U.S. generic prescription product portfolio of Australia’s Mayne Pharma Group for $105 million, which includes an upfront cash…

The market corrected for the second consecutive session amid rangebound and volatile trade, weighed by weakness in global counterparts, in the previous session. The BSE Sensex fell 168 points to 59,029, while the Nifty50 declined 31 points…

Stocks to Watch on Friday: The market closed lower in the last session for the first time in the last three consecutive sessions, due to selling pressure in late trade on the day of the expiry of August derivative contracts. Most of the key…

The market extended a strong rally for the second consecutive session with the benchmark indices closing at a nearly three-month high on July 28, the monthly expiry day for July F&O contracts. The rally was backed by buying across…

Nifty futures on the Singapore Exchange traded 162.5 points, or 1.03 per cent, higher at 15,863.50, signaling that Dalal Street was headed for a positive start on Monday. The market gained nearly a per cent in the last session, backed by…

DRL gets rights to commercialise proposed trastuzumab biosimilar in select LatAm, S-E Asia markets. Pharma major Dr. Reddy’s Laboratories has entered into a partnership with Prestige BioPharma under which it will get exclusive rights…

Talks to begin production of one-shot Covid-19 vaccine Sputnik Light in India are nearing completion, Russian news agency TASS quoted nagtion's External Affairs Minister Sergey Lavrov as saying on Monday.…

Set to receive $40 million upfront, approval milestone payment of upto $40 million later Dr. Reddy’s Laboratories has entered into a definitive agreement with Citius Pharmaceuticals Inc pursuant to which it sold all rights to E7777 (an…